Effect of therapeutic immunization with HIV type 1 recombinant glycoprotein 160 ImmunoAG vaccine in HIV-infected individuals with CD4+ T cell counts of >or=500 and 200-400/mm3 (AIDS Clinical Trials Group Study 246/946). (Q43778591)
Jump to navigation
Jump to search
scientific article published in October 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effect of therapeutic immunization with HIV type 1 recombinant glycoprotein 160 ImmunoAG vaccine in HIV-infected individuals with CD4+ T cell counts of >or=500 and 200-400/mm3 (AIDS Clinical Trials Group Study 246/946). |
scientific article published in October 2001 |
Statements
1 reference
Effect of therapeutic immunization with HIV type 1 recombinant glycoprotein 160 ImmunoAG vaccine in HIV-infected individuals with CD4+ T cell counts of >or=500 and 200-400/mm3 (AIDS Clinical Trials Group Study 246/946). (English)
1 reference
Kundu-Raychaudhuri S
1 reference
Sevin A
1 reference
Kilgo P
1 reference
Nokta M
1 reference
Pollard RB
1 reference
Merigan TC
1 reference
1 October 2001
1 reference
1 reference
17
1 reference
15
1 reference
1371-1378
1 reference
Identifiers
1 reference
1 reference